Assessment of humoral and cell-mediated immune response to measles-mumps-rubella vaccine viruses among patients with asthma

Allergy and Asthma Proceedings

Volumn 31, Issue 6, 2010, Pages 499-506

  Yoo, Kwang Ha ^a,b   Agarwal, Kanishtha ^b   Butterfield, Michael ^c   Jacobson, Robert M ^b   Poland, Gregory A ^b   Juhn, Young J ^b  

^a Konkuk University School of Medicine   (South Korea)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME IMMUNOASSAY; FAMILY HISTORY; FEMALE; HUMAN; HUMORAL IMMUNITY; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VIRUS; MUMPS; MUMPS VIRUS; PERIPHERAL BLOOD MONONUCLEAR CELL; RUBELLA; RUBELLA VIRUS; SCHOOL CHILD; T LYMPHOCYTE; TREATMENT DURATION; VACCINATION;

ADOLESCENT; ANTIGENS, VIRAL; ASTHMA; CELL PROLIFERATION; CHILD; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; MALE; MEASLES-MUMPS-RUBELLA VACCINE; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 78650444395     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2010.31.3399     Document Type: Article

References (30)

1. Brief report. Update: Mumps activity-United States, January 1-October 7, 2006. MMWR Morb Mortal Wkly Rep 55:1152-1153, 2006.
2. The Center for Disease Control and Prevention. Dales LG, Kizer KW, Rutherford GW, et al. Measles epidemic from failure to immunize. West J Med 159:455-464, 1993.
3. Dayan GH, Quinlisk MP, Parker AA, et al. Recent resurgence of mumps in the United States. N Engl J Med 358:1580-1589, 2008.
4. Poland G, Ovsyanniikova I, Jacobson R, et al. Identification of an association between HLA class II alleles and low antibody after measles immunization. Vaccine 20:430-438, 2002.
5. Boulianne N, De Serres G, Ratnam S, et al. Measles, mumps, and rubella antibodies in children 5-6 years after immunization: Effect of vaccine type and age at vaccination. Vaccine 13:1611-1616, 1995.
6. Harling R, White JM, Ramsay ME, et al. The effectiveness of the mumps component of the MMR vaccine: A case control study. Vaccine 23:4070-4074, 2005.
7. Katz SL, and Hinman AR. Summary and conclusions: Measles elimination meeting, 16-17 March 2000. J Infect Dis 189:S43-S47, 2004.
8. McQuillan GM, Kruszon-Moran D, Hyde TB, et al. Seroprevalence of measles antibody in the US population, 1999-2004. J Infect Dis 196:1459-1464, 2007.
9. Ovsyannikova IG, Jacobson RM, and Poland GA. Variation in vaccine response in normal populations. Pharmacogenomics 5:417-427, 2004.
10. Hahne S, Macey J, van Binnendijk R, et al. Rubella outbreak in the Netherlands, 2004-2005: High burden of congenital infection and spread to Canada. Pediatr Infect Dis J 28:795-800, 2009.
11. Asher MI, Montefort S, Björkstén B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 368:733-743, 2006.
12. Akinbami L. Asthma prevalence, health care use, and mortality: United States, 2003-2005: The National Center for Health Statistics 2006.
13. Beard CM, Yunginger JW, Reed CE, et al. Interobserver variability in medical record review: An epidemiological study of asthma. J Clin Epidemiol 45:1013-1020, 1992.
14. Grove DI, Burston TO, Wellby ML, et al. Humoral and cellular immunity in asthma. J Allergy Clin Immunol 55:152-163, 1975.
15. Noseworthy ME, Henderson AM, Kanzira P, et al. Measles, mumps and mycoplasma antibody profile in children with asthma. The 2005 Annual American Thoracic Society Meeting, San Diego, California.
16. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009. N Engl J Med 361:1935-1944, 2009.
17. Spika JS, Halsey NA, Fish AJ, et al. Serum antibody response to pneumococcal vaccine in children with nephrotic syndrome. Pediatrics 69:219-223, 1982.
18. Wilkins J, Leedom JM, Salvatore MA, et al. Clinical rubella with arthritis resulting from reinfection. Ann Intern Med 77:930-932, 1972.
19. Ovsyannikova IG, Jacobson RM, Vierkant RA, et al. Human leukocyte antigen class ii alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-ii vaccination. J Infect Dis 191:515-519, 2005.
20. Ovsyannikova IG, Jacobson RM, Vierkant RA, et al. HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: Findings and implications for vaccine design. Vaccine 25:3090-3100, 2007.
21. Dhiman N, Ovsyannikova IG, Jacobson RM, et al. Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children. Clin Immunol 115:154-161, 2005.
22. Juhn Y, Kita H, Lee L, et al. Childhood asthma and measles vaccine response. Ann Allergy Asthma Immunol 97:469-476, 2006.
23. Silverstein MD, Reed CE, O'Connell EJ, et al. Long-term survival of a cohort of community residents with asthma. N Engl J Med 331:1537-1541, 1994.
24. Yawn BP, Yunginger JW, Wollan PC, et al. Allergic rhinitis in Rochester, Minnesota residents with asthma: Frequency and impact on health care charges. J Allergy Clin Immunol 103:54-59, 1999.
25. Hayney MS, Poland GA, Jacobson RM, et al. Relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination. Int J Infect Dis 2:143-146, 1998.
26. Kremer JR, Schneider F, and Muller CP. Waning antibodies in measles and rubella vaccines - A longitudinal study. Vaccine 24:2594-2601, 2006.
27. Lahood N, Emerson SS, Kumar P, et al. Antibody levels and response to pneumococcal vaccine in steroid-dependent asthma. Ann Allergy 70:289-294, 1993.
28. Silberman H, Overturf GD, Field RJ, et al. Response of renal allograft recipients to pneumococcal vaccine. Ann Surg 192:199-201, 1980.
29. Grove DI, Reid JG, and Forbes IJ. Humoral and cellular immunity in atopic eczema. Br J Dermatol 92:611-618, 1975.
30. Atkinson TP, Duffy LB, Pendley D, et al. Deficient immune response to mycoplasma pneumoniae in childhood asthma. Allergy Asthma Proc 30:158-165, 2009.